Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Clinical trial NCT04672772 · COMPLETED

Trial details

NCT number: NCT04672772
Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Status: COMPLETED
Study type: OBSERVATIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2020-12-18
Primary completion: 2022-01-17
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.